tiprankstipranks
Astec Lifesciences Limited (IN:ASTEC)
:ASTEC
India Market
Want to see IN:ASTEC full AI Analyst Report?

Astec Lifesciences Limited (ASTEC) Price & Analysis

1 Followers

ASTEC Stock Chart & Stats

₹703.50
-₹43.60(-3.76%)
At close: 4:00 PM EST
₹703.50
-₹43.60(-3.76%)

Bulls Say, Bears Say

Bulls Say
Integrated Product MixAstec's vertically integrated portfolio—technical actives, chemical intermediates, and finished formulations—provides structural resilience. Owning multiple value‑chain stages supports margin capture, product substitution if one segment weakens, and cross‑sell opportunities to both domestic and export customers over the medium term.
Recent Top-line RecoveryThe FY26 revenue rebound indicates recovering demand or improved commercial execution, which is a durable positive if sustained. Higher scale can absorb fixed costs, restore utilization, and provide a platform for margin recovery and cash generation improvement over the coming months if management maintains pricing and mix.
Substantial Asset Base And Prior Positive Cash FlowA meaningful asset and equity base plus a history of positive operating cash flow in earlier years give the company structural resilience. These balance‑sheet resources support working‑capital needs, potential capex or restructuring, and provide lenders/partners greater confidence during cyclical recovery phases.
Bears Say
Sustained Losses And Cash BurnLarge, persistent net losses and heavy cash burn materially weaken internal funding capacity and erode equity cushions. Over a multi‑month horizon this forces reliance on external financing or asset sales, constrains reinvestment, and raises the risk that operating plans must be cut if cash flows do not show durable improvement.
Rising LeverageA marked increase in leverage reduces financial flexibility and raises refinancing and interest‑coverage risks, especially as earnings turned negative. Higher debt loads limit ability to fund growth or absorb shocks, and in a capital‑intensive chemical business can force higher finance costs or restrictive covenant pressures over months.
Profitability DeteriorationThe swing from solid profitability to sustained operating losses signals structural margin pressure—cost, mix, or pricing issues—that undermines return generation. Persistently negative operating profit limits reinvestment, damages ROE, and makes recovery dependent on operational fixes rather than transient market moves.

Astec Lifesciences Limited News

ASTEC FAQ

What was Astec Lifesciences Limited’s price range in the past 12 months?
Astec Lifesciences Limited lowest stock price was ₹512.35 and its highest was ₹990.88 in the past 12 months.
    What is Astec Lifesciences Limited’s market cap?
    Astec Lifesciences Limited’s market cap is ₹15.54B.
      When is Astec Lifesciences Limited’s upcoming earnings report date?
      Astec Lifesciences Limited’s upcoming earnings report date is Jul 29, 2026 which is in 87 days.
        How were Astec Lifesciences Limited’s earnings last quarter?
        Astec Lifesciences Limited released its earnings results on Apr 27, 2026. The company reported ₹0.5 earnings per share for the quarter, the consensus estimate of ₹0.5 by ₹0.
          Is Astec Lifesciences Limited overvalued?
          According to Wall Street analysts Astec Lifesciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Astec Lifesciences Limited pay dividends?
            Astec Lifesciences Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of N/A. See more information on Astec Lifesciences Limited dividends here
              What is Astec Lifesciences Limited’s EPS estimate?
              Astec Lifesciences Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Astec Lifesciences Limited have?
              Astec Lifesciences Limited has 22,282,238 shares outstanding.
                What happened to Astec Lifesciences Limited’s price movement after its last earnings report?
                Astec Lifesciences Limited reported an EPS of ₹0.5 in its last earnings report, expectations of ₹0.5. Following the earnings report the stock price went up 3.668%.
                  Which hedge fund is a major shareholder of Astec Lifesciences Limited?
                  Currently, no hedge funds are holding shares in IN:ASTEC
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Astec Lifesciences Limited

                    Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

                    Astec Lifesciences Limited (ASTEC) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Heranba Industries Limited
                    IG Petrochemicals Ltd.
                    IOL Chemicals & Pharmaceuticals Ltd.
                    Punjab Chemicals & Crop Protection Ltd.
                    Uniphos Enterprises Limited
                    Popular Stocks